RNA-Seq Blog Transcriptome Research & Industry News
Envisagenics, Inc., a biotechnology company that applies Artificial Intelligence to the genetic sequence of patients to discover new therapies, announced today that is has raised $2.35M in its seed round. The investors include Third Kind Venture Capital (3KVC), Cosine, LLC ...
Read More »Envisagenics closes $2.35M seed round and launches SpliceCore Platform for identifying RNA targets from splicing errors
